Sectors
Vernalis Licenses V2006 to RedoxTherapies Inc for Use in Immuno-Oncology
Vernalis plc today announces that it has licensed worldwide rights in vipadenant (V2006), a small molecule A2A receptor antagonist, to RedoxTherapies Inc (Redox). Vipadenant has the potential to disrupt an immunosuppressive mechanism of tumor protection, generating improved efficacy for immunotherapies of certain cancers when used in combination.
Bonhams to auction Lauren Bacall's art collection
An art collection amassed by the late movie star Lauren Bacall, including eight sculptures by Henry Moore, will go under the hammer next year in New York, Bonhams auction house said on Friday.
Ireland likely to phase out 'Double Irish' tax regime: sources
Ireland is set to announce legal changes next week to phase out the "Double Irish" tax arrangement that has let firms such as Google (GOOGL.O) save billions of dollars, two sources familiar with the matter said.
Egypt has paid back $500 million to Qatar: central bank governor
Egypt has paid back $500 million to Qatar and will soon return the remainder of the money the Gulf state deposited into the Egyptian central bank after the 2011 revolution, the bank's governor said on Saturday.